Israel - English - Ministry of Health

sanofi israel ltd - dronedarone - film coated tablets - dronedarone 400 mg - dronedarone - dronedarone - multaq is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (af). due to its safety profile, multaq should only be prescribed after alternative treatment options have been considered.multaq should not be given to patients with left ventricular systolic dysfunction or to patients with current or previous episodes of heart failure.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

diclofenac sodium

Australia - English - Department of Health (Therapeutic Goods Administration)

henry schein halas - 11168 - dentifrice - facilitates dental cleaning, surface polishing thus aiding routine oral prophylaxis

Australia - English - Department of Health (Therapeutic Goods Administration)

henry schein halas - 12440 - marker, - this device range helps mark plaque areas on a tooth and is thus intended to be used to aid disclose/make marks that allows identify dental plaque.

Australia - English - Department of Health (Therapeutic Goods Administration)

kkgm group pty ltd -

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - dronedarone (unii: jqz1l091y2) (dronedarone - unii:jqz1l091y2) - dronedarone 400 mg - multaq® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (af) [see clinical studies (14)] . multaq is contraindicated in patients with: - permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) [see boxed warning, warnings and precautions (5.2)] - symptomatic heart failure with recent decompensation requiring hospitalization or nyha class iv symptoms [see boxed warning, warnings and precautions (5.1)] - second or third-degree atrioventricular (av) block, or sick sinus syndrome (except when used in conjunction with a functioning pacemaker) - bradycardia <50 bpm - concomitant use of strong cyp3a inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see drug interactions (7.2)] - concomitant use of erythromycin [see clinical pharmacology (12.3)] - concomitant use of drugs or

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - dronedarone (unii: jqz1l091y2) (dronedarone - unii:jqz1l091y2) - dronedarone 400 mg - multaq® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (af) [see clinical studies (14)]. multaq is contraindicated in patients with: pregnancy category x [see contraindications (4)] multaq may cause fetal harm when administered to a pregnant woman. in animal studies, dronedarone was teratogenic in rats at the maximum recommended human dose (mrhd), and in rabbits at half the mrhd. if this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. when pregnant rats received dronedarone at oral doses greater than or equal to the mrhd (on a mg/m2 basis), fetuses had increased rates of external, visceral and skeletal malformations (cranioschisis, cleft palate, incomplete evagination of pineal body, brachygnathia, partially fused carotid arteries, truncus arteriosus, abnormal lobation of the liver,

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - dronedarone (unii: jqz1l091y2) (dronedarone - unii:jqz1l091y2) - dronedarone 400 mg - multaq® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (af) [see clinical studies (14)]. multaq is contraindicated in patients with: - permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) [see boxed warning and warnings and precautions (5.2)] - symptomatic heart failure with recent decompensation requiring hospitalization or nyha class iv symptoms [see boxed warning and warnings and precautions (5.1)] - second- or third-degree atrioventricular (av) block, or sick sinus syndrome (except when used in conjunction with a functioning pacemaker) - bradycardia <50 bpm - concomitant use of strong cyp 3a inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see drug interactions (7.2)] - concomitant use of drugs or herbal products that prolong the qt interval and might incr

United States - English - NLM (National Library of Medicine)

total suncare llc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - avobenzone 3 ml in 100 ml - purpose sunscreen uses - helps prevent sunburn   - higher spf gives more sunburn protection  - provides moderate protection against sunburn - retains spf after 40 minutes of activity in the water directions - apply evenly before sun exposure and as needed. - hold can about 6in away from body and spray onto skin. - do not spray onto face - spray into palm and smooth over face and neck. - children under 6 months of age: ask a doctor. - reapply as needed or after towel drying, swimming, or perspiring. other information - sun alert: limiting sun exposure, wearing protective clothing, and using sunscreens may   reduce the risks of skin aging, skin cancer, and other harmful effects of the sun. - may stain some fabrics - avoid long term storage above 104 degrees f - for your protection, this bottle has an imprinted seal around the neck. do not use if   tamper evident seal is missing, tampered, broken, or destroyed.

United States - English - NLM (National Library of Medicine)

total suncare llc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - avobenzone 2 ml in 100 ml - purpose sunscreen uses - helps prevent sunburn   - higher spf gives more sunburn protection  - provides moderate protection against sunburn - retains spf after 40 minutes of activity in the water directions - apply evenly before sun exposure and as needed. - hold can about 6in away from body and spray onto skin. - do not spray onto face - spray into palm and smooth over face and neck. - children under 6 months of age: ask a doctor. - reapply as needed or after towel drying, swimming, or perspiring. other information - sun alert: limiting sun exposure, wearing protective clothing, and using sunscreens may   reduce the risks of skin aging, skin cancer, and other harmful effects of the sun. - may stain some fabrics - avoid long term storage above 104 degrees f - for your protection, this bottle has an imprinted seal around the neck. do not use if   tamper evident seal is missing, tampered, broken, or destroyed.